Chromosomal Imbalance in the Progression of High-Risk Non-Muscle Invasive Bladder Cancer Editorial Comment

被引：0
|
作者：
Montie, James E.
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 03期
关键词：
D O I：
10.1016/j.juro.2009.11.100
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：938 / 939
页数：2
相关论文
共 50 条
  • [1] Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
    Zieger, Karsten
    Wiuf, Carsten
    Jensen, Klaus Moller-Ernst
    Orntoft, Torben Falck
    Dyrskjot, Lars
    BMC CANCER, 2009, 9
  • [2] Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
    Karsten Zieger
    Carsten Wiuf
    Klaus Møller-Ernst Jensen
    Torben Falck Ørntoft
    Lars Dyrskjøt
    BMC Cancer, 9 (1)
  • [3] Management of high-risk non-muscle invasive bladder cancer
    Brausi, M.
    Olaru, V.
    MINERVA UROLOGICA E NEFROLOGICA, 2012, 64 (04) : 255 - 260
  • [4] The Promise of Radiotherapy in High-Risk Non-Muscle Invasive Bladder Cancer
    Bola, Becky
    Hoskin, Peter J.
    Sangar, Vijay
    Choudhury, Ananya
    CANCERS, 2025, 17 (04)
  • [5] Genomic characterization of high-risk non-muscle invasive bladder cancer
    Meeks, Joshua J.
    Carneiro, Benedito A.
    Pai, Sachin G.
    Oberlin, Daniel T.
    Rademaker, Alfred
    Fedorchak, Kyle
    Balasubramanian, Sohail
    Elvin, Julia
    Beaubier, Nike
    Giles, Francis J.
    ONCOTARGET, 2016, 7 (46) : 75176 - 75184
  • [6] Pembrolizumab monotherapy for high-risk, non-muscle invasive bladder cancer
    Balar, Arjun, V
    Kamat, Ashish M.
    de Wit, Ronald
    LANCET ONCOLOGY, 2021, 22 (09): : E380 - E380
  • [7] Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer
    Bashir Al Hussein Al Awamlh
    Sam S. Chang
    Current Oncology Reports, 2023, 25 : 83 - 91
  • [8] Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer
    Al Awamlh, Bashir Al Hussein
    Chang, Sam S.
    CURRENT ONCOLOGY REPORTS, 2023, 25 (02) : 83 - 91
  • [9] Tumor mutation burden to predict progression in high-risk non-muscle invasive bladder cancer.
    Meeks, Joshua
    Carneiro, Benedito A.
    Pai, Sachin Gopalkrishn
    Oberlin, Daniel
    Rademaker, Alfred
    Fedorchak, Kyle
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [10] THE OUTCOME OF PATIENTS WITH HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER IN SWEDEN
    Wang, Eugen
    Larsson, Ulf
    Gardmark, Truls
    Malmstrom, Per-Uno
    JOURNAL OF UROLOGY, 2020, 203 : E1077 - E1077
12345